T43.225D
T43.225D: Adverse effect of selective serotonin reuptake inhibitors, subsequent encounter
Billable / specific codeICD-10-CMPOA exempt
T43.225D is a billable, specific ICD-10-CM code for adverse effect of selective serotonin reuptake inhibitors, subsequent encounter. It is valid for submission on a claim.
Check T43.225D with the rest of the claim: free scrubber7th character "D": subsequent encounter
The appropriate 7th character is to be added to each code from category T43
- A
- initial encounter
- D
- subsequent encounter
- S
- sequela
Excludes2 inherited from the categories above T43.225D
Not part of this code, but both may be coded when both are present.
Written on T43: Poisoning by, adverse effect of and underdosing of psychotropic drugs, not elsewhere classified
Risk adjustment
No CMS-HCC V28 category: this code does not change a RAF score.
Medicare coverage
T43.225D is named in 18 Medicare coverage policies: 18 listing it as supporting medical necessity. Which one applies depends on your Medicare contractor.
- A56531Billing and Coding: Octreotide Acetate for Injectable Suspension (Sandostatin® LAR Depot)
- A56612Billing and Coding: CT of the Head
- A56625Billing and Coding: Echocardiography
- A56645Billing and Coding: Controlled Substance Monitoring and Drugs of Abuse Testing
Code history
Unchanged in every release from FY2024 to FY2027.